Multi Center Trial Resources

The Trial Innovation Network is a collaborative initiative within the CTSA Program and is composed of three key organizational partners – the CTSA Program Hubs, the Trial Innovation Centers (TICs), and the Recruitment Innovation Center (RIC).

The vision for the Trial Innovation Network is to innovatively address critical roadblocks in clinical trials and accelerate the translation of novel interventions into life-saving therapies. The Trial Innovation Network is a collaborative national network that focuses on operational innovation, operational excellence and collaboration and will leverage the expertise and resources of the CTSA Program. The Trial Innovation Network will feature a single IRB system, master contracting agreements, quality by design approaches, and a focus on evidence-based strategies to recruitment and patient engagement.

The goal of the Trial Innovation Network is to not only execute trials better, faster, and more cost-efficiently but, importantly, to be a national laboratory to study, understand and innovate the process of conducting clinical trials.

The investigators are currently building the key elements of the Trial Innovation Network. The goal is to start early projects as soon as possible and collaborate with other NIH Institutes and partners to launch clinical trials in 2017.

Visit the Trial Innovation Network

CTSI, in collaboration with five other CTSA sites in the Midwest (University of Wisconsin-Madison, Mayo Clinic, University of Minnesota, Indiana State University and Ohio State University), has formed a consortium – MARCH (Midwest Area Research Consortium for Health) to enable the most cost effective and efficient conduct of a multisite clinical trial at one or all of these Universities.

The aim of MARCH is to conduct trials under one IRB submission one contract for all sites. The CTO acts as a gateway to MARCH services for CTSI investigators.

Visit the MARCH Website

TriNetX is a federated clinical data network of providers, pharmaceutical companies and contract research organizations (CROs) used to enhance clinical trial design and accelerate trial site and patient recruitment. TriNetX membership increases the flow of sponsored research to providers and enables pharmaceutical companies to find the right patients at the right sites for clinical trials.

The TriNetX Network can facilitate participation in new industry-sponsored clinical trials while improving the design and subject accrual for clinical studies. TriNetX also supports deeper insights into a patient cohort to enhance your investigators’ research programs, and enables them to collaborate with peers and other member institutions.

Benefits

• Access to more Clinical Trials – Fund your research with sponsorship from pharmaceutical companies.
• Exploratory Research – Better understand the target patient population to aid in development of a study protocol.
• Patient Recruitment – Identify patients that meet study eligibility criteria.
• Create Peer Networks – Collaborate with other TriNetX members nationally.

Visit the TriNetX website.